C
Healthpeak Properties, Inc.
DOC
$18.17
-$0.47-2.52%
C
Hold
2/6/2025Downgrade
Healthpeak Properties, Inc. (DOC) was downgraded to C- from C on 2/6/2025 due to a noticeable decline in the growth index, valuation index and volatility index. Earnings per share declined from $0.1224 to $0.0063, operating cash flow declined 10.9% from $318.2M to $283.53M, and total revenue declined 0.34% from $700.4M to $697.99M.
Healthpeak Properties, Inc. (DOC) was downgraded to C- from C on 2/6/2025 due to a noticeable decline in the growth index, valuation index and volatility index. Earnings per share declined from $0.1224 to $0.0063, operating cash flow declined 10.9% from $318.2M to $283.53M, and total revenue declined 0.34% from $700.4M to $697.99M.
C
Hold
8/30/2024Upgraded
Healthpeak Properties, Inc. (DOC) was upgraded to C from C- on 8/30/2024 due to an increase in the volatility index and total return index.
Healthpeak Properties, Inc. (DOC) was upgraded to C from C- on 8/30/2024 due to an increase in the volatility index and total return index.
C
Hold
8/15/2024Downgrade
Healthpeak Properties, Inc. (DOC) was downgraded to C- from C on 8/15/2024 due to a decline in the valuation index, efficiency index and volatility index.
Healthpeak Properties, Inc. (DOC) was downgraded to C- from C on 8/15/2024 due to a decline in the valuation index, efficiency index and volatility index.
C
Hold
7/26/2024Upgraded
Healthpeak Properties, Inc. (DOC) was upgraded to C from C- on 7/26/2024 due to an increase in the volatility index, total return index and dividend index.
Healthpeak Properties, Inc. (DOC) was upgraded to C from C- on 7/26/2024 due to an increase in the volatility index, total return index and dividend index.
C
Hold
4/18/2023Downgrade
Healthpeak Properties, Inc. (PEAK) was downgraded to C- from C on 4/18/2023 due to a decline in the volatility index, valuation index and total return index.
Healthpeak Properties, Inc. (PEAK) was downgraded to C- from C on 4/18/2023 due to a decline in the volatility index, valuation index and total return index.
C
Hold
4/3/2023Upgraded
Healthpeak Properties, Inc. (PEAK) was upgraded to C from C- on 4/3/2023 due to an increase in the valuation index, volatility index and dividend index.
Healthpeak Properties, Inc. (PEAK) was upgraded to C from C- on 4/3/2023 due to an increase in the valuation index, volatility index and dividend index.
C
Hold
3/17/2023Downgrade
Healthpeak Properties, Inc. (PEAK) was downgraded to C- from C on 3/17/2023 due to a decline in the volatility index, efficiency index and total return index. Net income declined 98.16% from $353.97M to $6.53M.
Healthpeak Properties, Inc. (PEAK) was downgraded to C- from C on 3/17/2023 due to a decline in the volatility index, efficiency index and total return index. Net income declined 98.16% from $353.97M to $6.53M.
C
Hold
1/30/2023Upgraded
Healthpeak Properties, Inc. (PEAK) was upgraded to C from C- on 1/30/2023 due to an increase in the volatility index and total return index.
Healthpeak Properties, Inc. (PEAK) was upgraded to C from C- on 1/30/2023 due to an increase in the volatility index and total return index.
C
Hold
11/3/2022Upgraded
Healthpeak Properties, Inc. (PEAK) was upgraded to C- from D+ on 11/3/2022 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from $0.1255 to $0.6491, EBIT increased 5.15% from $96.75M to $101.73M, and total revenue increased 0.48% from $517.93M to $520.41M.
Healthpeak Properties, Inc. (PEAK) was upgraded to C- from D+ on 11/3/2022 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from $0.1255 to $0.6491, EBIT increased 5.15% from $96.75M to $101.73M, and total revenue increased 0.48% from $517.93M to $520.41M.
D
Sell
8/29/2022Downgrade
Healthpeak Properties, Inc. (PEAK) was downgraded to D+ from C- on 8/29/2022 due to a decline in the total return index, volatility index and valuation index.
Healthpeak Properties, Inc. (PEAK) was downgraded to D+ from C- on 8/29/2022 due to a decline in the total return index, volatility index and valuation index.
C
Hold
8/5/2022Downgrade
Healthpeak Properties, Inc. (PEAK) was downgraded to C- from C on 8/5/2022 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $0.1291 to $0.1255.
Healthpeak Properties, Inc. (PEAK) was downgraded to C- from C on 8/5/2022 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $0.1291 to $0.1255.
C
Hold
5/23/2022Downgrade
Healthpeak Properties, Inc. (PEAK) was downgraded to C from C+ on 5/23/2022 due to a decline in the volatility index and total return index.
Healthpeak Properties, Inc. (PEAK) was downgraded to C from C+ on 5/23/2022 due to a decline in the volatility index and total return index.
C
Hold
5/6/2022Upgraded
Healthpeak Properties, Inc. (PEAK) was upgraded to C+ from C on 5/6/2022 due to a major increase in the growth index and dividend index. Earnings per share increased from $0.0529 to $0.1291, EBIT increased 11.01% from $80.29M to $89.13M, and total revenue increased 3.14% from $483.21M to $498.37M.
Healthpeak Properties, Inc. (PEAK) was upgraded to C+ from C on 5/6/2022 due to a major increase in the growth index and dividend index. Earnings per share increased from $0.0529 to $0.1291, EBIT increased 11.01% from $80.29M to $89.13M, and total revenue increased 3.14% from $483.21M to $498.37M.
C
Hold
4/25/2022Downgrade
Healthpeak Properties, Inc. (PEAK) was downgraded to C from C+ on 4/25/2022 due to a decline in the volatility index, valuation index and dividend index.
Healthpeak Properties, Inc. (PEAK) was downgraded to C from C+ on 4/25/2022 due to a decline in the volatility index, valuation index and dividend index.
C
Hold
2/11/2022Downgrade
Healthpeak Properties, Inc. (PEAK) was downgraded to C+ from B- on 2/11/2022 due to a major decline in the growth index, valuation index and total return index. Earnings per share declined from $0.101 to $0.0529, and EBIT declined 0.73% from $80.88M to $80.29M.
Healthpeak Properties, Inc. (PEAK) was downgraded to C+ from B- on 2/11/2022 due to a major decline in the growth index, valuation index and total return index. Earnings per share declined from $0.101 to $0.0529, and EBIT declined 0.73% from $80.88M to $80.29M.
B
Buy
1/11/2022Upgraded
Healthpeak Properties, Inc. (PEAK) was upgraded to B- from C+ on 1/11/2022 due to an increase in the total return index.
Healthpeak Properties, Inc. (PEAK) was upgraded to B- from C+ on 1/11/2022 due to an increase in the total return index.
C
Hold
12/27/2021Downgrade
Healthpeak Properties, Inc. (PEAK) was downgraded to C+ from B- on 12/27/2021 due to a noticeable decline in the total return index and volatility index.
Healthpeak Properties, Inc. (PEAK) was downgraded to C+ from B- on 12/27/2021 due to a noticeable decline in the total return index and volatility index.
B
Buy
11/8/2021Downgrade
Healthpeak Properties, Inc. (PEAK) was downgraded to B- from B on 11/8/2021 due to a large decline in the growth index, total return index and solvency index. Earnings per share declined from $0.5095 to $0.101, debt to equity increased from 0.73 to 0.83, and operating cash flow declined 10.61% from $236.87M to $211.74M.
Healthpeak Properties, Inc. (PEAK) was downgraded to B- from B on 11/8/2021 due to a large decline in the growth index, total return index and solvency index. Earnings per share declined from $0.5095 to $0.101, debt to equity increased from 0.73 to 0.83, and operating cash flow declined 10.61% from $236.87M to $211.74M.
B
Buy
11/3/2021Upgraded
Healthpeak Properties, Inc. (PEAK) was upgraded to B from B- on 11/3/2021 due to an increase in the total return index, valuation index and volatility index.
Healthpeak Properties, Inc. (PEAK) was upgraded to B from B- on 11/3/2021 due to an increase in the total return index, valuation index and volatility index.
B
Buy
8/6/2021Upgraded
Healthpeak Properties, Inc. (PEAK) was upgraded to B- from C+ on 8/6/2021 due to a significant increase in the growth index, solvency index and total return index. Operating cash flow increased 93.01% from $122.73M to $236.87M, earnings per share increased from $0.2661 to $0.5095, and debt to equity declined from 0.85 to 0.73.
Healthpeak Properties, Inc. (PEAK) was upgraded to B- from C+ on 8/6/2021 due to a significant increase in the growth index, solvency index and total return index. Operating cash flow increased 93.01% from $122.73M to $236.87M, earnings per share increased from $0.2661 to $0.5095, and debt to equity declined from 0.85 to 0.73.
C
Hold
4/22/2021Upgraded
Healthpeak Properties, Inc. (PEAK) was upgraded to C+ from C on 4/22/2021 due to a large increase in the total return index, growth index and valuation index. Earnings per share increased from -$0.12 to $0.2714.
Healthpeak Properties, Inc. (PEAK) was upgraded to C+ from C on 4/22/2021 due to a large increase in the total return index, growth index and valuation index. Earnings per share increased from -$0.12 to $0.2714.
C
Hold
8/27/2020Upgraded
Healthpeak Properties, Inc. (PEAK) was upgraded to C from C- on 8/27/2020 due to a large increase in the valuation index, solvency index and growth index. EBIT increased 473.58% from -$17.34M to $64.76M, operating cash flow increased 136.51% from $95.04M to $224.78M, and total revenue increased 0.56% from $585.15M to $588.44M.
Healthpeak Properties, Inc. (PEAK) was upgraded to C from C- on 8/27/2020 due to a large increase in the valuation index, solvency index and growth index. EBIT increased 473.58% from -$17.34M to $64.76M, operating cash flow increased 136.51% from $95.04M to $224.78M, and total revenue increased 0.56% from $585.15M to $588.44M.
C
Hold
3/12/2020Downgrade
Healthpeak Properties, Inc. (PEAK) was downgraded to C- from C on 3/12/2020 due to a decline in the volatility index and total return index.
Healthpeak Properties, Inc. (PEAK) was downgraded to C- from C on 3/12/2020 due to a decline in the volatility index and total return index.
C
Hold
2/18/2020Downgrade
Healthpeak Properties, Inc. (PEAK) was downgraded to C from B- on 2/18/2020 due to a significant decline in the valuation index, growth index and efficiency index. EBIT declined 24.82% from $93.67M to $70.42M, operating cash flow declined 12.32% from $248.04M to $217.47M, and total revenue declined 1.17% from $537.97M to $531.69M.
Healthpeak Properties, Inc. (PEAK) was downgraded to C from B- on 2/18/2020 due to a significant decline in the valuation index, growth index and efficiency index. EBIT declined 24.82% from $93.67M to $70.42M, operating cash flow declined 12.32% from $248.04M to $217.47M, and total revenue declined 1.17% from $537.97M to $531.69M.
B
Buy
8/2/2019Upgraded
HCP, Inc. (HCP) was upgraded to B- from C on 8/2/2019 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 39.98% from $158.58M to $221.98M, and total revenue increased 12.7% from $436.15M to $491.57M.
HCP, Inc. (HCP) was upgraded to B- from C on 8/2/2019 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 39.98% from $158.58M to $221.98M, and total revenue increased 12.7% from $436.15M to $491.57M.
C
Hold
5/7/2019Downgrade
HCP, Inc. (HCP) was downgraded to C from C+ on 5/7/2019 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $1.7401 to $0.1277, operating cash flow declined 26.51% from $215.79M to $158.58M, and debt to equity increased from 0.94 to 1.01.
HCP, Inc. (HCP) was downgraded to C from C+ on 5/7/2019 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $1.7401 to $0.1277, operating cash flow declined 26.51% from $215.79M to $158.58M, and debt to equity increased from 0.94 to 1.01.
C
Hold
2/15/2019Upgraded
HCP, Inc. (HCP) was upgraded to C+ from C on 2/15/2019 due to a significant increase in the valuation index, growth index and efficiency index. Net income increased 736.81% from $99.37M to $831.55M, earnings per share increased from $0.21 to $1.7401, and operating cash flow increased 11.67% from $193.24M to $215.79M.
HCP, Inc. (HCP) was upgraded to C+ from C on 2/15/2019 due to a significant increase in the valuation index, growth index and efficiency index. Net income increased 736.81% from $99.37M to $831.55M, earnings per share increased from $0.21 to $1.7401, and operating cash flow increased 11.67% from $193.24M to $215.79M.
C
Hold
12/11/2018Upgraded
HCP, Inc. (HCP) was upgraded to C from C- on 12/11/2018 due to an increase in the total return index and volatility index.
HCP, Inc. (HCP) was upgraded to C from C- on 12/11/2018 due to an increase in the total return index and volatility index.
C
Hold
11/26/2018Downgrade
HCP, Inc. (HCP) was downgraded to C- from C on 11/26/2018 due to a decline in the volatility index and valuation index.
HCP, Inc. (HCP) was downgraded to C- from C on 11/26/2018 due to a decline in the volatility index and valuation index.
C
Hold
11/7/2018Upgraded
HCP, Inc. (HCP) was upgraded to C from C- on 11/7/2018 due to a large increase in the volatility index, valuation index and total return index.
HCP, Inc. (HCP) was upgraded to C from C- on 11/7/2018 due to a large increase in the volatility index, valuation index and total return index.
C
Hold
7/18/2018Upgraded
HCP, Inc. (HCP) was upgraded to C- from D+ on 7/18/2018 due to an increase in the growth index and total return index. EBIT increased 3,461.91% from -$4.19M to $140.76M, earnings per share increased from -$0.1297 to $0.08, and total revenue increased 8.11% from $443.26M to $479.2M.
HCP, Inc. (HCP) was upgraded to C- from D+ on 7/18/2018 due to an increase in the growth index and total return index. EBIT increased 3,461.91% from -$4.19M to $140.76M, earnings per share increased from -$0.1297 to $0.08, and total revenue increased 8.11% from $443.26M to $479.2M.
D
Sell
2/15/2018Downgrade
HCP, Inc. (HCP) was downgraded to D+ from C- on 2/15/2018 due to a major decline in the growth index, valuation index and volatility index. Earnings per share declined from -$0.02 to -$0.1297, EBIT declined 102.97% from $140.99M to -$4.19M, and total revenue declined 2.37% from $454.02M to $443.26M.
HCP, Inc. (HCP) was downgraded to D+ from C- on 2/15/2018 due to a major decline in the growth index, valuation index and volatility index. Earnings per share declined from -$0.02 to -$0.1297, EBIT declined 102.97% from $140.99M to -$4.19M, and total revenue declined 2.37% from $454.02M to $443.26M.
C
Hold
10/23/2017Downgrade
HCP, Inc. (HCP) was downgraded to C- from C on 10/23/2017 due to a large decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.9748 to $0.04, net income declined 95.8% from $461.15M to $19.38M, and EBIT declined 44.4% from $173M to $96.18M.
HCP, Inc. (HCP) was downgraded to C- from C on 10/23/2017 due to a large decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.9748 to $0.04, net income declined 95.8% from $461.15M to $19.38M, and EBIT declined 44.4% from $173M to $96.18M.
C
Hold
5/26/2017Upgraded
HCP, Inc. (HCP) was upgraded to C from C- on 5/26/2017 due to a significant increase in the valuation index, growth index and efficiency index. Earnings per share increased from $0.12 to $0.9748, and net income increased 686.12% from $58.66M to $461.15M.
HCP, Inc. (HCP) was upgraded to C from C- on 5/26/2017 due to a significant increase in the valuation index, growth index and efficiency index. Earnings per share increased from $0.12 to $0.9748, and net income increased 686.12% from $58.66M to $461.15M.
C
Hold
11/4/2016Downgrade
HCP, Inc. (HCP) was downgraded to C- from C on 11/4/2016 due to a noticeable decline in the growth index, total return index and solvency index. Earnings per share declined from $0.6444 to $0.32, operating cash flow declined 16.71% from $398.3M to $331.72M, and EBIT declined 6.28% from $303.35M to $284.29M.
HCP, Inc. (HCP) was downgraded to C- from C on 11/4/2016 due to a noticeable decline in the growth index, total return index and solvency index. Earnings per share declined from $0.6444 to $0.32, operating cash flow declined 16.71% from $398.3M to $331.72M, and EBIT declined 6.28% from $303.35M to $284.29M.
C
Hold
8/12/2016Upgraded
HCP, Inc. (HCP) was upgraded to C from C- on 8/12/2016 due to a noticeable increase in the growth index, volatility index and efficiency index. Net income increased 159.83% from $116.12M to $301.72M, earnings per share increased from $0.2484 to $0.6444, and operating cash flow increased 48.28% from $268.62M to $398.3M.
HCP, Inc. (HCP) was upgraded to C from C- on 8/12/2016 due to a noticeable increase in the growth index, volatility index and efficiency index. Net income increased 159.83% from $116.12M to $301.72M, earnings per share increased from $0.2484 to $0.6444, and operating cash flow increased 48.28% from $268.62M to $398.3M.
C
Hold
3/11/2016Downgrade
HCP, Inc. (HCP) was downgraded to C- from C on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
HCP, Inc. (HCP) was downgraded to C- from C on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
C
Hold
5/8/2015Downgrade
HCP, Inc. (HCP) was downgraded to C from B- on 5/8/2015 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $0.4202 to -$0.52, operating cash flow declined 37.07% from $365.6M to $230.07M, and debt to equity increased from 0.91 to 0.97.
HCP, Inc. (HCP) was downgraded to C from B- on 5/8/2015 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $0.4202 to -$0.52, operating cash flow declined 37.07% from $365.6M to $230.07M, and debt to equity increased from 0.91 to 0.97.
B
Buy
5/1/2015Downgrade
HCP, Inc. (HCP) was downgraded to B- from B on 5/1/2015 due to a decline in the volatility index and total return index.
HCP, Inc. (HCP) was downgraded to B- from B on 5/1/2015 due to a decline in the volatility index and total return index.
B
Buy
4/16/2015Upgraded
HCP, Inc. (HCP) was upgraded to B from B- on 4/16/2015 due to an increase in the volatility index and valuation index.
HCP, Inc. (HCP) was upgraded to B from B- on 4/16/2015 due to an increase in the volatility index and valuation index.
B
Buy
2/13/2015Downgrade
HCP, Inc. (HCP) was downgraded to B- from B on 2/13/2015 due to a noticeable decline in the growth index, valuation index and volatility index. Earnings per share declined from $0.5388 to $0.4202, and EBIT declined 4.7% from $349.11M to $332.69M.
HCP, Inc. (HCP) was downgraded to B- from B on 2/13/2015 due to a noticeable decline in the growth index, valuation index and volatility index. Earnings per share declined from $0.5388 to $0.4202, and EBIT declined 4.7% from $349.11M to $332.69M.
B
Buy
10/17/2014Upgraded
HCP, Inc. (HCP) was upgraded to B from B- on 10/17/2014 due to an increase in the volatility index and total return index.
HCP, Inc. (HCP) was upgraded to B from B- on 10/17/2014 due to an increase in the volatility index and total return index.
B
Buy
9/18/2014Downgrade
HCP, Inc. (HCP) was downgraded to B- from B on 9/18/2014 due to a large decline in the volatility index, solvency index and growth index. Earnings per share declined from $0.5643 to $0.4766, EBIT declined 3.21% from $325.5M to $315.06M, and debt to equity increased from 0.79 to 0.81.
HCP, Inc. (HCP) was downgraded to B- from B on 9/18/2014 due to a large decline in the volatility index, solvency index and growth index. Earnings per share declined from $0.5643 to $0.4766, EBIT declined 3.21% from $325.5M to $315.06M, and debt to equity increased from 0.79 to 0.81.
B
Buy
7/18/2014Downgrade
HCP, Inc. (HCP) was downgraded to B from B+ on 7/18/2014 due to a decline in the total return index and valuation index.
HCP, Inc. (HCP) was downgraded to B from B+ on 7/18/2014 due to a decline in the total return index and valuation index.
B
Buy
7/3/2014Upgraded
HCP, Inc. (HCP) was upgraded to B+ from B on 7/3/2014 due to an increase in the volatility index, total return index and valuation index.
HCP, Inc. (HCP) was upgraded to B+ from B on 7/3/2014 due to an increase in the volatility index, total return index and valuation index.
B
Buy
5/6/2014Upgraded
HCP, Inc. (HCP) was upgraded to B from B- on 5/6/2014 due to an increase in the volatility index and efficiency index. Net income increased 25.39% from $233.76M to $293.1M, and total capital increased 0.94% from $19.42B to $19.6B.
HCP, Inc. (HCP) was upgraded to B from B- on 5/6/2014 due to an increase in the volatility index and efficiency index. Net income increased 25.39% from $233.76M to $293.1M, and total capital increased 0.94% from $19.42B to $19.6B.
NYSE
04/10/2025 4:00PM Eastern
Quotes delayed
